The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 137-141

  Lau, Thorsten ^a   Schloss, Patrick ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Cannabinoid CB1 receptor; Dopamine; Neuron; Serotonin

Indexed keywords

ANTIBODY; CANNABINOID 1 RECEPTOR; DOPAMINE; DOPAMINE TRANSPORTER; SEROTONIN; SEROTONIN TRANSPORTER; SLC18A2 PROTEIN, MOUSE; SLC6A4 PROTEIN, MOUSE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER;

ARTICLE; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; NEURITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC NERVE CELL; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; EMBRYONIC STEM CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EMBRYONIC STEM CELLS; IMMUNOHISTOCHEMISTRY; MICE; NEURITES; NEURONS; RECEPTOR, CANNABINOID, CB1; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 37349082417     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.022     Document Type: Article

References (40)

1. Adell A., and Artigas F. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci. Biobehav. Rev. 28 (2004) 415-431
2. Adell A., Celada P., Abellan M.T., and Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Brain Res. Rev. 39 (2002) 154-180
3. 1 receptor and the 5-HT transporter in the rat amygdale. Eur. J. Pharmacol. 537 (2006) 70-71
4. Bacci A., Huguenard J.R., and Prince D.A. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431 (2004) 312-316
5. Bagdy E., and Harsing Jr. L.G. The role of various calcium and potassium channels in the regulation of somatodendritic serotonin release. Neurochem. Res. 20 (1995) 1409-1415
6. Bustos G., Abarca J., Campusano J., Bustos V., Noriega V., and Aliaga E. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res. Brain Res. Rev. 47 (2004) 126-144
7. Castellano C., Rossi-Arnaud C., Cestari V., and Costanzi M. Cannabinoids and memory: animal studies. Curr. Drug Targets CNS. Neurol. Disord. 2 (2003) 389-402
8. Chen N., Appell M., Berfield J.L., and Reith M.E. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur. J. Pharmacol. 478 (2003) 89-95
9. Chen B.T., Moran K.A., Avshalumov M.V., and Rice M.E. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release. J. Neurochem. 96 (2006) 645-655
10. Chhatwal J.P., Davis M., Maguschak K.A., and Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 30 (2005) 516-524
11. De-Miguel F.F., and Trueta C. Synaptic and extrasynaptic secretion of serotonin. Cell. Mol. Neurobiol. 25 (2005) 297-312
12. Egashira N., Mishima K., Katsurabayashi S., Yoshitake T., Matsumoto Y., Ishida J., Yamaguchi M., Iwasaki K., and Fujiwara M. Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. Eur. J. Pharmacol. 445 (2002) 221-229
13. Glickfeld L.L., and Scanziani M. Self-administering cannabinoids. Trends Neurosci. 28 (2005) 341-343
14. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., and Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U S A. 102 (2005) 18620-18625
15. 1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol. Psychiatry 57 (2005) 261-267
16. Hill M.N., and Gorzalka B.B. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?. Behav. Pharmacol. 16 (2005) 333-352
17. 1 receptor mediates fear extinction via habituation-like processes. J. Neurosci. 26 (2006) 6677-6686
18. 1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 359 (1999) 466-470
19. Kenney S.P., Kekuda R., Prasad P.D., Leibach F.H., Devoe L.D., and Ganapathy V. Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am. J. Obstet. Gynecol. 181 (1999) 491-497
20. Lau T., Adam S., and Schloss P. Rapid and efficient differentiation of dopaminergic neurons from mouse embryonic stem cells. Neuroreport 17 (2006) 975-979
21. Liu J., Wang L., Harvey-White J., Osei-Hyiaman D., Razdan R., Gong Q., Chan A.C., Zhou Z., Huang B.X., Kim H.Y., and Kunos G. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. U S A. 103 (2006) 13345-13350
22. Maldonado R., and Rodriguez de Fonseca F. Cannabinoid addiction: behavioral models and neural correlates. J. Neurosci. 22 (2002) 3326-3331
23. Malone D.T., and Taylor D.A. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br. J. Pharmacol. 128 (1999) 21-26
24. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgansberger W., Di Marzo V., and Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (2002) 530-534
25. 1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159 (2002) 379-387
26. 1 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 361 (2000) 19-24
27. Oropeza V.C., Mackie K., and Van Bockstaele E.J. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 1127 (2007) 36-44
28. Pamplona F.A., Prediger R.D., Pandolfo P., and Takahashi R.N. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl) 188 (2006) 641-649
29. Ranganathan M., and D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 188 (2006) 425-444
30. Rolletschek A., Chang H., Guan K., Czyz J., Meyer M., and Wobus A.M. Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech. Dev. 105 (2001) 93-104
31. 1 knockout mice. Psychopharmacology (Berl) 176 (2004) 223-232
32. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22 (2001) 565-572
33. Schlicker E., Timm J., and Gothert M. Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 791-795
34. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 583-589
35. Sur C., Betz H., and Schloss P. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73 (1996) 217-231
36. 1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138 (2003) 544-553
37. Vinod K.Y., and Hungund B.L. Role of the endocannabinoid system in depression and suicide. Trends Pharmacol. Sci. 27 (2006) 539-545
38. Vizi E.S., Kiss J.P., and Lendvai B. Nonsynaptic communication in the central nervous system. Neurochem. Int. 45 (2004) 443-451
39. Wilson R.I., and Nicoll R.A. Endocannabinoid signaling in the brain. Science 296 (2002) 678-682
40. 1 receptors in mood and anxiety disorders. Behav. Pharmacol. 16 (2005) 315-331